Genome-Wide Screening of Genes Regulated by DNA Methylation in Colon Cancer Development

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Spisák, Sándor ^a   Kalmár, Alexandra ^b   Galamb, Orsolya ^a,b   Wichmann, Barna ^b   Sipos, Ferenc ^b   Péterfia, Bálint ^b   Csabai, István ^c,d   Kovalszky, Ilona ^b   Semsey, Szabolcs ^e   Tulassay, Zsolt ^a,b   Molnár, Béla ^a,b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; GLUCAGON; TRANSCRIPTOME;

ARTICLE; CANCER CELL CULTURE; COLON CARCINOGENESIS; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; DOWN REGULATION; EPITHELIUM CELL; FAM161B GENE; GCG GENE; GENE EXPRESSION PROFILING; GENE INACTIVATION; GENETIC IDENTIFICATION; GENETIC SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LRMP GENE; NMES 1 GENE; PTGDR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; TUMOR GENE; UPREGULATION;

ADENOCARCINOMA; COLONIC NEOPLASMS; DNA METHYLATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MICROARRAY ANALYSIS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PRINCIPAL COMPONENT ANALYSIS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 84866976386     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046215     Document Type: Article

References (68)

1. Fearon ER, (1992) Genetic alterations underlying colorectal tumorigenesis. Cancer Surv 12: 119-136.
2. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, et al. (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532.
3. Grady WM, (2005) Epigenetic events in the colorectum and in colon cancer. Biochem Soc Trans 33: 684-688.
4. Grady WM, Markowitz SD, (2002) Genetic and epigenetic alterations in colon cancer. Annu Rev Genomics Hum Genet 3: 101-128.
5. Bennett KL, Campbell R, Ganapathi S, Zhou M, Rini B, et al. (2011) Germline and somatic DNA methylation and epigenetic regulation of KILLIN in renal cell carcinoma. Genes Chromosomes Cancer.
6. Kim T, Veronese A, Pichiorri F, Lee TJ, Jeon YJ, et al. (2011) p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med 208: 875-883.
7. Zhang H, Pan Y, Zheng L, Choe C, Lindgren B, et al. (2011) FOXO1 Inhibits Runx2 Transcriptional Activity and Prostate Cancer Cell Migration and Invasion. Cancer Res 71: 3257-3267.
8. Siedlecki P, Zielenkiewicz P, (2006) Mammalian DNA methyltransferases. Acta Biochim Pol 53: 245-256.
9. Eden S, Cedar H, (1994) Role of DNA methylation in the regulation of transcription. Curr Opin Genet Dev 4: 255-259.
10. Issa JP (2000) The epigenetics of colorectal cancer. Ann N Y Acad Sci 910: 140-153; discussion 153-145.
11. Kulis M, Esteller M, (2010) DNA methylation and cancer. Adv Genet 70: 27-56.
12. Helman E, Naxerova K, Kohane IS (2011) DNA hypermethylation in lung cancer is targeted at differentiation-associated genes. Oncogene.
13. Carmona FJ, Esteller M, (2010) Epigenomics of human colon cancer. Mutat Res 693: 53-60.
14. Gan LH, Chen SJ, Zhong J, Wang XA, Lam EKY, et al. (2011) ZIC1 Is Downregulated through Promoter Hypermethylation, and Functions as a Tumor Suppressor Gene in Colorectal Cancer. Plos One 6: e16916.
15. Karpf AR, Lasek AW, Ririe TO, Hanks AN, Grossman D, et al. (2004) Limited gene activation in tumor and normal epithelial cells treated with the DNA methyltransferase inhibitor 5-aza-2′-deoxycytidine. Mol Pharmacol 65: 18-27.
16. Ku JL, Kang SB, Shin YK, Kang HC, Hong SH, et al. (2004) Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines. Oncogene 23: 6736-6742.
17. Li H, Myeroff L, Smiraglia D, Romero MF, Pretlow TP, et al. (2003) SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers. Proceedings of the National Academy of Sciences of the United States of America 100: 8412-8417.
18. Huang B, Qu Z, Ong CW, Tsang YH, Xiao G, et al. (2011) RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor alpha. Oncogene.
19. Sato N, Matsubayashi H, Abe T, Fukushima N, Goggins M, (2005) Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling. Clinical cancer research: an official journal of the American Association for Cancer Research 11: 4681-4688.
20. Ogoshi K, Hashimoto S, Nakatani Y, Qu W, Oshima K, et al. (2011) Genome-wide profiling of DNA methylation in human cancer cells. Genomics 98: 280-287.
21. Zhai R, Zhao Y, Su L, Cassidy L, Liu G, et al. (2012) Genome-wide DNA methylation profiling of cell-free serum DNA in esophageal adenocarcinoma and Barrett esophagus. Neoplasia 14: 29-33.
22. Bibikova M, Chudin E, Wu B, Zhou L, Garcia EW, et al. (2006) Human embryonic stem cells have a unique epigenetic signature. Genome research 16: 1075-1083.
23. Bibikova M, Lin Z, Zhou L, Chudin E, Garcia EW, et al. (2006) High-throughput DNA methylation profiling using universal bead arrays. Genome research 16: 383-393.
24. Landegren U (2009) Selective amplification of mutant DNA: mutations come to light in melting DNA. Hum Mutat 30: v.
25. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, et al. (2009) Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462: 315-322.
26. Xiong Z, Laird PW, (1997) COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 25: 2532-2534.
27. Barrier A, Lemoine A, Boelle PY, Tse C, Brault D, et al. (2005) Colon cancer prognosis prediction by gene expression profiling. Oncogene 24: 6155-6164.
28. Spisak S, Kalmar A, Galamb O, Sipos F, Wichmann B, et al. (2010) [Identification of methylation related genes from laser capture microdissected colon samples during investigation of adenoma-carcinoma sequence]. Orvosi hetilap 151: 805-814.
29. Chen L, Borozan I, Milkiewicz P, Sun J, Meng XB, et al. (2008) Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid. Liver International 28: 997-1010.
30. Galamb O, Sipos F, Spisak S, Galamb B, Krenacs T, et al. (2009) Potential biomarkers of colorectal adenoma-dysplasia-carcinoma progression: mRNA expression profiling and in situ protein detection on TMAs reveal 15 sequentially upregulated and 2 downregulated genes. Cell Oncol 31: 19-29.
31. Ostrowski J, Polkowski M, Paziewska A, Skrzypczak M, Goryca K, et al. (2009) Functional features of gene expression profiles differentiating gastrointestinal stromal tumours according to KIT mutations and expression. Bmc Cancer 9: 413.
32. Guo Y, Engelhardt M, Wider D, Abdelkarim M, Lubbert M, (2006) Effects of 5-aza-2′-deoxycytidine on proliferation, differentiation and p15/INK4b regulation of human hematopoietic progenitor cells. Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, UK 20: 115-121.
33. Xiong H, Qiu H, Zhuang L, Jiang R, Chen Y, (2009) Effects of 5-Aza-CdR on the proliferation of human breast cancer cell line MCF-7 and on the expression of Apaf-1 gene. Journal of Huazhong University of Science and Technology Medical sciences = Hua zhong ke ji da xue xue bao Yi xue Ying De wen ban = Huazhong keji daxue xuebao Yixue Yingdewen ban 29: 498-502.
34. Zhang B, Huang T, Liu K, Chen J, Wang G, (2007) Effects of 5-Aza-CdR on cell proliferation of breast cancer cell line MDA-MB-435S and expression of maspin gene. Journal of Huazhong University of Science and Technology Medical sciences = Hua zhong ke ji da xue xue bao Yi xue Ying De wen ban = Huazhong keji daxue xuebao Yixue Yingdewen ban 27: 543-546.
35. Spisak S, Molnar B, Galamb O, Sipos F, Tulassay Z, (2007) [Theoretical foundations of protein chips and their possible use in medical research and diagnostics]. Orv Hetil 148: 1511-1520.
36. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, et al. (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clinical chemistry 55: 611-622.
37. Uemura M, Zheng Q, Koh CM, Nelson WG, Yegnasubramanian S, et al. (2011) Overexpression of ribosomal RNA in prostate cancer is common but not linked to rDNA promoter hypomethylation. Oncogene.
38. Sabates-Bellver J, Van der Flier LG, de Palo M, Cattaneo E, Maake C, et al. (2007) Transcriptome profile of human colorectal adenomas. Mol Cancer Res 5: 1263-1275.
39. Matsuyama T, Ishikawa T, Mogushi K, Yoshida T, Iida S, et al. (2010) MUC12 mRNA expression is an independent marker of prognosis in stage II and stage III colorectal cancer. Int J Cancer 127: 2292-2299.
40. Pearson K, (1901) On lines and planes of closest fit to systems of points in space. Philosophical Magazine 2: 559-572.
41. Galamb O, Sipos F, Solymosi N, Spisak S, Krenacs T, et al. (2008) Diagnostic mRNA expression patterns of inflamed, benign, and malignant colorectal biopsy specimen and their correlation with peripheral blood results. Cancer Epidemiol Biomarkers Prev 17: 2835-2845.
42. Bertucci F, Salas S, Eysteries S, Nasser V, Finetti P, et al. (2004) Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene 23: 1377-1391.
43. Sung JC, McCarthy S, Turner J, Li CG, Yeatman TJ, (2004) The NBL1 tumor suppressor gene is downregulated in colon cancer by promoter methylation. Journal of the American College of Surgeons 199: S92-S92.
44. Suzuki H, Zhou X, Yin J, Lei J, Jiang HY, et al. (1995) Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers. Hum Mol Genet 4: 1883-1887.
45. Prall F, Ostwald C, Weirich V, Nizze H, (2006) p16(INK4a) promoter methylation and 9p21 allelic loss in colorectal carcinomas: relation with immunohistochemical p16(INK4a) expression and with tumor budding. Hum Pathol 37: 578-585.
46. Herman JG, Civin CI, Issa JP, Collector MI, Sharkis SJ, et al. (1997) Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res 57: 837-841.
47. Sanchez-Aguilera A, Delgado J, Camacho FI, Sanchez-Beato M, Sanchez L, et al. (2004) Silencing of the p18(INK4c) gene by promoter hypermethylation in Reed-Sternberg cells in Hodgkin lymphomas. Blood 103: 2351-2357.
48. Wu CC, Shyu RY, Chou JM, Jao SW, Chao PC, et al. (2006) RARRES1 expression is significantly related to tumour differentiation and staging in colorectal adenocarcinoma. Eur J Cancer 42: 557-565.
49. Bader S, Walker M, Hendrich B, Bird A, Bird C, et al. (1999) Somatic frameshift mutations in the MBD4 gene of sporadic colon cancers with mismatch repair deficiency. Oncogene 18: 8044-8047.
50. Traicoff JL, De Marchis L, Ginsburg BL, Zamora RE, Khattar NH, et al. (2003) Characterization of the human polymeric immunoglobulin receptor (PIGR) 3′UTR and differential expression of PIGR mRNA during colon tumorigenesis. J Biomed Sci 10: 792-804.
51. Surawska H, Ma PC, Salgia R, (2004) The role of ephrins and Eph receptors in cancer. Cytokine Growth Factor Rev 15: 419-433.
52. Zhang Z, Huettner PC, Nguyen L, Bidder M, Funk MC, et al. (2006) Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer. Oncogene 25: 5436-5445.
53. Zhou J, Wang H, Lu A, Hu G, Luo A, et al. (2002) A novel gene, NMES1, downregulated in human esophageal squamous cell carcinoma. Int J Cancer 101: 311-316.
54. Sova P, Feng Q, Geiss G, Wood T, Strauss R, et al. (2006) Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis. Cancer Epidemiol Biomarkers Prev 15: 114-123.
55. Drucker DJ, (2003) Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. Mol Endocrinol 17: 161-171.
56. Sugino Y, Misawa A, Inoue J, Kitagawa M, Hosoi H, et al. (2007) Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas. Oncogene 26: 7401-7413.
57. Wang S, Wang L, Zhu T, Gao X, Li J, et al. (2010) Improvement of tissue preparation for laser capture microdissection: application for cell type-specific miRNA expression profiling in colorectal tumors. BMC Genomics 11: 163.
58. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, et al. (2001) Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nature genetics 29: 365-371.
59. Liu CL, Schreiber SL, Bernstein BE, (2003) Development and validation of a T7 based linear amplification for genomic DNA. BMC Genomics 4: 19.
60. Liu CL, Bernstein BE, Schreiber SL (2008) Whole Genome Amplification by T7-Based Linear Amplification of DNA (TLAD): II. Second-Strand Synthesis and In Vitro Transcription. CSH protocols 2008: pdb prot5003.
61. Galamb O, Spisak S, Sipos F, Toth K, Solymosi N, et al. (2010) Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor. Br J Cancer 102: 765-773.
62. Spisak S, Tulassay Z, Molnar B, Guttman A, (2007) Protein microchips in biomedicine and biomarker discovery. Electrophoresis 28: 4261-4273.
63. Meyer D, Zeileis A, Hornik K, (2006) The strucplot framework: visualizing multi-way contingency tables with VCD. Journal of Statistical Software 17: 1-48.
64. Pfaffl MW, Horgan GW, Dempfle L, (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30: e36.
65. Shain EB, Clemens JM, (2008) A new method for robust quantitative and qualitative analysis of real-time PCR. Nucleic Acids Res 36: e91.
66. Rice P, Longden I, Bleasby A, (2000) EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet 16: 276-277.
67. Li LC, Dahiya R, (2002) MethPrimer: designing primers for methylation PCRs. Bioinformatics 18: 1427-1431.
68. Tusnady GE, Simon I, Varadi A, Aranyi T, (2005) BiSearch: primer-design and search tool for PCR on bisulfite-treated genomes. Nucleic Acids Res 33: e9.